Susan Morse
President Trump directed HHS and the CDC to evaluate the scientific evidence of childhood vaccinations in other peer, developed nations.
Merger isn't the result of failing financials, but of leveraging scale in an incredibly complex system, according to health systems.
Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.
Model enables state Medicaid agencies and Medicare Part D to cover GLP-1 drugs.
HHS has appealed and has been joined by several pharmaceutical companies that want intervenor status.
Mail-order pharmacies run by UnitedHealth and Humana have the most cost overruns, says WSJ report.
Partnership will allow Maimonides to adopt a new EHR and access a higher Medicaid rate.
Novo Nordisk has beaten Eli Lilly in releasing the first oral GLP-1 for weight loss in adults.
The health system expects over $40 million in net revenue improvement on an annualized basis.
Dr. Paul Krakovitz will join the North Carolina health system in 2026.